NeoThelium FT
NeoThelium FT is an intervention with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
2
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds
Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Open Wounds
Evaluating the Efficacy of NeoThelium FT in the Treatment of Venous Leg Ulcers
Evaluating the Efficacy of NeoThelium FT in the Treatment of Pressure Injuries
Clinical Trials (5)
Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds
Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Open Wounds
Evaluating the Efficacy of NeoThelium FT in the Treatment of Venous Leg Ulcers
Evaluating the Efficacy of NeoThelium FT in the Treatment of Pressure Injuries
All 5 trials loaded
Drug Details
- Intervention Type
- Other
- Total Trials
- 5